How Pictor Labs is turning tissue into data to revolutionize diagnosis

Histopathology, the practice of examining tissue samples under a microscope to diagnose diseases, is a cornerstone of modern medicine. It enables clinicians to confirm conditions like cancer, assess disease progression, and guide treatment plans. However, the fundamental technology behind this process has remained largely unchanged for over a century. When a biopsy is sent to a laboratory for testing, it is sliced into paper-thin sections that are dipped into a sequence of chemical dyes. These dyes "stain" the tissue samples, revealing hidden cellular structures that help doctors make diagnoses. Despite its importance, this traditional staining process has significant drawbacks.

The conventional staining workflow is slow and resource-intensive. Labs often batch samples together, leading to delays in providing results to doctors. In some cases, it can take days for test results to reach clinicians, and even longer for those results to move through reporting systems, consultations, and scheduling before patients can receive appropriate treatment. Furthermore, the chemical staining process consumes and alters tissue sections, leaving less material available for subsequent critical steps such as molecular diagnostics, genetic sequencing, and other precision medicine processes.

Yair Rivenson, co-founder and CEO of digital pathology startup Pictor Labs, encountered these challenges firsthand while working as a researcher at UCLA in 2019. Alongside co-founder Aydogan Ozcan, Rivenson was involved in deep learning microscopy research, which led him to question why histopathologists still relied on limited physical tissue samples in an era dominated by digital and AI technologies. "For me," Rivenson recalls, "the question was immediately, why can't we teach a computer to do that? Why do we need the chemistry part?"

Pictor Labs was founded to address this issue by simulating the staining process using software. "The information is there," explains Rivenson. "We can basically image the tissue, edit it as it is in its native form, and compute that contrast so that the pathologist can study the same exact tissue in the exact same way that they're currently doing." By leveraging advanced imaging technologies and machine learning algorithms, Pictor Labs aims to revolutionize the histopathology workflow, enabling faster, more efficient, and resource-friendly analysis of tissue samples.

The company's innovative approach allows pathologists to bypass the time-consuming and labor-intensive chemical staining process. Instead, Pictor Labs uses high-resolution microscopy to capture detailed images of tissue samples, which are then processed using AI-driven algorithms to enhance contrast and visualize cellular structures. This digital staining method not only accelerates the diagnostic process but also preserves the integrity of the tissue samples, ensuring that they remain available for further testing and research.

Rivenson and Ozcan's vision for Pictor Labs is to transform the way histopathology is conducted, making it more accessible and efficient for healthcare professionals around the world. By turning tissue into data through advanced imaging and AI, the startup seeks to reduce diagnostic delays, improve accuracy, and ultimately enhance patient outcomes. As the demand for precision medicine continues to grow, Pictor Labs' innovative technology has the potential to reshape the diagnostic landscape and pave the way for more effective treatments and better healthcare delivery.

In the face of these challenges, Pictor Labs is poised to revolutionize the field of histopathology by replacing traditional chemical staining with a digital, AI-driven approach. By leveraging cutting-edge technology, the company is working to streamline the diagnostic process, preserve valuable tissue samples, and empower pathologists with powerful new tools to make more informed decisions about patient care. As the world moves towards a future where data-driven medicine becomes increasingly prevalent, Pictor Labs is at the forefront of this transformation, determined to turn tissue into data and revolutionize diagnosis.